Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1999 Mar;64(3):832–838. doi: 10.1086/302280

Identifying families with likely genetic protective factors against Alzheimer disease.

J M Silverman 1, C J Smith 1, D B Marin 1, S Birstein 1, M Mare 1, R C Mohs 1, K L Davis 1
PMCID: PMC1377801  PMID: 10053018

Abstract

Elderly individuals who lived beyond the age of 90 years without dementia were hypothesized to have increased concentrations of genetic protective factors against Alzheimer disease (AD), conferring a reduced liability for this disease relative to less-aged nondemented elderly. However, testing this hypothesis is complicated by having to distinguish such a group from those who may lack genetic risk factors for AD, have had protective environmental exposures, or have escaped dementia for other reasons. Probands carrying genetic protective factors, however, should have relatives with lower illness rates not only for earlier-onset disease, when genetic risk factors are a strong contributing factor to the incidence of AD, but also for later-onset disease, when the role of these factors appears to be markedly diminished. AD dementia was assessed through family informants in 6,660 first-degree relatives of 1,049 nondemented probands aged 60-102 years. The probands were grouped by age (60-74, 75-89, and 90-102 years), and the cumulative survival from AD and 10-year-age-interval hazard rates of AD were calculated in their first-degree relatives. Cumulative survival from AD was significantly greater in the relatives of the oldest proband group (aged 90-102 years) than it was in the two younger groups. In addition, the reduction in the rate of illness for this group was relatively constant across the entire late life span. The results suggest that genetic factors conferring a lifelong reduced liability of AD may be more highly concentrated among nondemented probands aged >/=90 years and their relatives. Efforts to identify protective allele-bearing genes that are associated with very late-onset AD should target the families of nonagenarians and centenarians.

Full Text

The Full Text of this article is available as a PDF (224.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asada T., Yamagata Z., Kinoshita T., Kinoshita A., Kariya T., Asaka A., Kakuma T. Prevalence of dementia and distribution of ApoE alleles in Japanese centenarians: an almost-complete survey in Yamanashi Prefecture, Japan. J Am Geriatr Soc. 1996 Feb;44(2):151–155. doi: 10.1111/j.1532-5415.1996.tb02431.x. [DOI] [PubMed] [Google Scholar]
  2. Blacker D., Haines J. L., Rodes L., Terwedow H., Go R. C., Harrell L. E., Perry R. T., Bassett S. S., Chase G., Meyers D. ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology. 1997 Jan;48(1):139–147. doi: 10.1212/wnl.48.1.139. [DOI] [PubMed] [Google Scholar]
  3. Brayne C., Harrington C. R., Wischik C. M., Huppert F. A., Chi L. Y., Xuereb J. H., O'Connor D. W., Paykel E. S. Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population. Dementia. 1996 May-Jun;7(3):169–174. doi: 10.1159/000106873. [DOI] [PubMed] [Google Scholar]
  4. Breitner J. C., Folstein M. F. Familial Alzheimer Dementia: a prevalent disorder with specific clinical features. Psychol Med. 1984 Feb;14(1):63–80. doi: 10.1017/s0033291700003081. [DOI] [PubMed] [Google Scholar]
  5. Chartier-Harlin M. C., Parfitt M., Legrain S., Pérez-Tur J., Brousseau T., Evans A., Berr C., Vidal O., Roques P., Gourlet V. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet. 1994 Apr;3(4):569–574. doi: 10.1093/hmg/3.4.569. [DOI] [PubMed] [Google Scholar]
  6. Corder E. H., Lannfelt L., Viitanen M., Corder L. S., Manton K. G., Winblad B., Basun H. Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Arch Neurol. 1996 May;53(5):418–422. doi: 10.1001/archneur.1996.00550050048022. [DOI] [PubMed] [Google Scholar]
  7. Corder E. H., Saunders A. M., Risch N. J., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Jr, Rimmler J. B., Locke P. A., Conneally P. M., Schmader K. E. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994 Jun;7(2):180–184. doi: 10.1038/ng0694-180. [DOI] [PubMed] [Google Scholar]
  8. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993 Aug 13;261(5123):921–923. doi: 10.1126/science.8346443. [DOI] [PubMed] [Google Scholar]
  9. Curran M., Middleton D., Edwardson J., Perry R., McKeith I., Morris C., Neill D. HLA-DR antigens associated with major genetic risk for late-onset Alzheimer's disease. Neuroreport. 1997 Apr 14;8(6):1467–1469. doi: 10.1097/00001756-199704140-00028. [DOI] [PubMed] [Google Scholar]
  10. Dean M., Carrington M., Winkler C., Huttley G. A., Smith M. W., Allikmets R., Goedert J. J., Buchbinder S. P., Vittinghoff E., Gomperts E. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science. 1996 Sep 27;273(5283):1856–1862. doi: 10.1126/science.273.5283.1856. [DOI] [PubMed] [Google Scholar]
  11. Farrer L. A., Cupples L. A., Haines J. L., Hyman B., Kukull W. A., Mayeux R., Myers R. H., Pericak-Vance M. A., Risch N., van Duijn C. M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997 Oct 22;278(16):1349–1356. [PubMed] [Google Scholar]
  12. Gessner R., Reischies F. M., Kage A., Geiselmann B., Borchelt M., Steinhagen-Thiessen E., Köttgen E. In an epidemiological sample the apolipoprotein E4 allele is associated to dementia and loss of memory function only in the very old. Neurosci Lett. 1997 Jan 24;222(1):29–32. doi: 10.1016/s0304-3940(97)13334-1. [DOI] [PubMed] [Google Scholar]
  13. Goate A., Chartier-Harlin M. C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991 Feb 21;349(6311):704–706. doi: 10.1038/349704a0. [DOI] [PubMed] [Google Scholar]
  14. Hebert L. E., Scherr P. A., Beckett L. A., Albert M. S., Pilgrim D. M., Chown M. J., Funkenstein H. H., Evans D. A. Age-specific incidence of Alzheimer's disease in a community population. JAMA. 1995 May 3;273(17):1354–1359. [PubMed] [Google Scholar]
  15. Helkala E. L., Koivisto K., Hanninen T., Vanhanen M., Kervinen K., Kuusisto J., Mykkanen L., Kesaniemi Y. A., Laakso M., Riekkinen P., Sr Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study. Neurosci Lett. 1996 Feb 9;204(3):177–180. doi: 10.1016/0304-3940(96)12348-x. [DOI] [PubMed] [Google Scholar]
  16. Heun R., Maier W. Risk of Alzheimer's disease in first-degree relatives. Arch Gen Psychiatry. 1995 Apr;52(4):317–319. doi: 10.1001/archpsyc.1995.03950160067014. [DOI] [PubMed] [Google Scholar]
  17. Higgins G. A., Large C. H., Rupniak H. T., Barnes J. C. Apolipoprotein E and Alzheimer's disease: a review of recent studies. Pharmacol Biochem Behav. 1997 Apr;56(4):675–685. doi: 10.1016/s0091-3057(96)00420-0. [DOI] [PubMed] [Google Scholar]
  18. Hirose N., Homma S., Arai Y., Kawamura M., Hasegawa H., Ishida H., Shimizu K., Osono Y., Homma A., Nakamura Y. [Tokyo Centenarian Study. 4. Apolipoprotein E phenotype in Japanese centenarians living in the Tokyo Metropolitan area]. Nihon Ronen Igakkai Zasshi. 1997 Apr;34(4):267–272. doi: 10.3143/geriatrics.34.267. [DOI] [PubMed] [Google Scholar]
  19. Hirst C., Yee I. M., Sadovnick A. D. Genetic factors that protect against dementia. Am J Hum Genet. 1994 Sep;55(3):588–589. [PMC free article] [PubMed] [Google Scholar]
  20. Kawas C., Segal J., Stewart W. F., Corrada M., Thal L. J. A validation study of the Dementia Questionnaire. Arch Neurol. 1994 Sep;51(9):901–906. doi: 10.1001/archneur.1994.00540210073015. [DOI] [PubMed] [Google Scholar]
  21. Lautenschlager N. T., Cupples L. A., Rao V. S., Auerbach S. A., Becker R., Burke J., Chui H., Duara R., Foley E. J., Glatt S. L. Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old? Neurology. 1996 Mar;46(3):641–650. doi: 10.1212/wnl.46.3.641. [DOI] [PubMed] [Google Scholar]
  22. Levy-Lahad E., Wijsman E. M., Nemens E., Anderson L., Goddard K. A., Weber J. L., Bird T. D., Schellenberg G. D. A familial Alzheimer's disease locus on chromosome 1. Science. 1995 Aug 18;269(5226):970–973. doi: 10.1126/science.7638621. [DOI] [PubMed] [Google Scholar]
  23. Li G., Aryan M., Silverman J. M., Haroutunian V., Perl D. P., Birstein S., Lantz M., Marin D. B., Mohs R. C., Davis K. L. The validity of the family history method for identifying Alzheimer disease. Arch Neurol. 1997 May;54(5):634–640. doi: 10.1001/archneur.1997.00550170104021. [DOI] [PubMed] [Google Scholar]
  24. Li G., Silverman J. M., Smith C. J., Zaccario M. L., Schmeidler J., Mohs R. C., Davis K. L. Age at onset and familial risk in Alzheimer's disease. Am J Psychiatry. 1995 Mar;152(3):424–430. doi: 10.1176/ajp.152.3.424. [DOI] [PubMed] [Google Scholar]
  25. Liu R., Paxton W. A., Choe S., Ceradini D., Martin S. R., Horuk R., MacDonald M. E., Stuhlmann H., Koup R. A., Landau N. R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 1996 Aug 9;86(3):367–377. doi: 10.1016/s0092-8674(00)80110-5. [DOI] [PubMed] [Google Scholar]
  26. Mayeux R., Sano M., Chen J., Tatemichi T., Stern Y. Risk of dementia in first-degree relatives of patients with Alzheimer's disease and related disorders. Arch Neurol. 1991 Mar;48(3):269–273. doi: 10.1001/archneur.1991.00530150037014. [DOI] [PubMed] [Google Scholar]
  27. Payami H., Grimslid H., Oken B., Camicioli R., Sexton G., Dame A., Howieson D., Kaye J. A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype. Am J Hum Genet. 1997 Apr;60(4):948–956. [PMC free article] [PubMed] [Google Scholar]
  28. Payami H., Montee K., Kaye J. Evidence for familial factors that protect against dementia and outweigh the effect of increasing age. Am J Hum Genet. 1994 Apr;54(4):650–657. [PMC free article] [PubMed] [Google Scholar]
  29. Sandbrink R., Hartmann T., Masters C. L., Beyreuther K. Genes contributing to Alzheimer's disease. Mol Psychiatry. 1996 Mar;1(1):27–40. [PubMed] [Google Scholar]
  30. Scacchi R., De Bernardini L., Mantuano E., Donini L. M., Vilardo T., Corbo R. M. Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of epsilon 4 allele with AD in Italian octogenarian patients. Neurosci Lett. 1995 Dec 15;201(3):231–234. doi: 10.1016/0304-3940(95)12190-0. [DOI] [PubMed] [Google Scholar]
  31. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995 Jun 29;375(6534):754–760. doi: 10.1038/375754a0. [DOI] [PubMed] [Google Scholar]
  32. Silverman J. M., Breitner J. C., Mohs R. C., Davis K. L. Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. Am J Psychiatry. 1986 Oct;143(10):1279–1282. doi: 10.1176/ajp.143.10.1279. [DOI] [PubMed] [Google Scholar]
  33. Silverman J. M., Keefe R. S., Mohs R. C., Davis K. L. A study of the reliability of the family history method in genetic studies of Alzheimer disease. Alzheimer Dis Assoc Disord. 1989 Winter;3(4):218–223. [PubMed] [Google Scholar]
  34. Silverman J. M., Li G., Schear S., Wang Z. X., Sotolongo C., Somary K., Mohs R. C. A cross-cultural family history study of primary progressive dementia in relatives of nondemented elderly Chinese, Italians, Jews and Puerto Ricans. Acta Psychiatr Scand. 1992 Mar;85(3):211–217. doi: 10.1111/j.1600-0447.1992.tb08597.x. [DOI] [PubMed] [Google Scholar]
  35. Silverman J. M., Li G., Zaccario M. L., Smith C. J., Schmeidler J., Mohs R. C., Davis K. L. Patterns of risk in first-degree relatives of patients with Alzheimer's disease. Arch Gen Psychiatry. 1994 Jul;51(7):577–586. doi: 10.1001/archpsyc.1994.03950070069012. [DOI] [PubMed] [Google Scholar]
  36. Sobel E., Louhija J., Sulkava R., Davanipour Z., Kontula K., Miettinen H., Tikkanen M., Kainulainen K., Tilvis R. Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology. 1995 May;45(5):903–907. doi: 10.1212/wnl.45.5.903. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES